Advance consent for dementia research.

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Informed consent is a fundamental ethical concern for dementia research that involves the participation of human subjects. The central dilemma is how to obtain valid informed consent from a population of potential subjects who are losing their decision-making capacity while still providing adequate protection for this vulnerable group of people. One model for informed consent for dementia research would be to obtain consent in advance of the loss of decision-making capacity, perhaps using written advance directives similar to those used for clinical decisions on life-sustaining treatments. This article examines the advance consent model, contrasts the life-sustaining treatment arena with dementia research issues, and suggests that written advance consent should not be required to conduct dementia research. Instead, an argument is presented in favor of a more informal advance consent process that builds upon the existing practice of using subject assent plus proxy consent.

Original languageEnglish (US)
Pages (from-to)19-27
Number of pages9
JournalAlzheimer Disease and Associated Disorders
Volume8 Suppl 4
StatePublished - 1994
Externally publishedYes

Fingerprint

Dementia
Informed Consent
Research
Decision Making
Advance Directives
Proxy
Therapeutics
Population

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Advance consent for dementia research. / Sachs, Greg.

In: Alzheimer Disease and Associated Disorders, Vol. 8 Suppl 4, 1994, p. 19-27.

Research output: Contribution to journalArticle

@article{3a346f2f7bf04d0ca4fb87a3102d2ad8,
title = "Advance consent for dementia research.",
abstract = "Informed consent is a fundamental ethical concern for dementia research that involves the participation of human subjects. The central dilemma is how to obtain valid informed consent from a population of potential subjects who are losing their decision-making capacity while still providing adequate protection for this vulnerable group of people. One model for informed consent for dementia research would be to obtain consent in advance of the loss of decision-making capacity, perhaps using written advance directives similar to those used for clinical decisions on life-sustaining treatments. This article examines the advance consent model, contrasts the life-sustaining treatment arena with dementia research issues, and suggests that written advance consent should not be required to conduct dementia research. Instead, an argument is presented in favor of a more informal advance consent process that builds upon the existing practice of using subject assent plus proxy consent.",
author = "Greg Sachs",
year = "1994",
language = "English (US)",
volume = "8 Suppl 4",
pages = "19--27",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Advance consent for dementia research.

AU - Sachs, Greg

PY - 1994

Y1 - 1994

N2 - Informed consent is a fundamental ethical concern for dementia research that involves the participation of human subjects. The central dilemma is how to obtain valid informed consent from a population of potential subjects who are losing their decision-making capacity while still providing adequate protection for this vulnerable group of people. One model for informed consent for dementia research would be to obtain consent in advance of the loss of decision-making capacity, perhaps using written advance directives similar to those used for clinical decisions on life-sustaining treatments. This article examines the advance consent model, contrasts the life-sustaining treatment arena with dementia research issues, and suggests that written advance consent should not be required to conduct dementia research. Instead, an argument is presented in favor of a more informal advance consent process that builds upon the existing practice of using subject assent plus proxy consent.

AB - Informed consent is a fundamental ethical concern for dementia research that involves the participation of human subjects. The central dilemma is how to obtain valid informed consent from a population of potential subjects who are losing their decision-making capacity while still providing adequate protection for this vulnerable group of people. One model for informed consent for dementia research would be to obtain consent in advance of the loss of decision-making capacity, perhaps using written advance directives similar to those used for clinical decisions on life-sustaining treatments. This article examines the advance consent model, contrasts the life-sustaining treatment arena with dementia research issues, and suggests that written advance consent should not be required to conduct dementia research. Instead, an argument is presented in favor of a more informal advance consent process that builds upon the existing practice of using subject assent plus proxy consent.

UR - http://www.scopus.com/inward/record.url?scp=0028709659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028709659&partnerID=8YFLogxK

M3 - Article

VL - 8 Suppl 4

SP - 19

EP - 27

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

ER -